GABA-B receptor neurons represent a major population of inhibitory neurons in the central nervous system that express the metabotropic GABA-B receptor. Unlike ionotropic GABA-A receptors that mediate fast synaptic inhibition, GABA-B receptors are G protein-coupled receptors (GPCRs) that produce slow, prolonged inhibitory effects through G-protein signaling pathways[1]. This page provides a comprehensive analysis of GABA-B receptor neurons, their molecular mechanisms, and their emerging roles in neurodegenerative diseases including Alzheimer's disease and Parkinson's disease.
The GABA-B receptor is a unique heterodimeric GPCR composed of two distinct subunits[2]:
GABA-B1 Subunit:
GABA-B2 Subunit:
Heterodimer Formation:
GABA-B receptor activation triggers multiple intracellular signaling cascades[3]:
Gi/o Protein-Coupled Signaling:
Presynaptic Effects:
Postsynaptic Effects:
Alternative Signaling:
GABA-B receptors are widely distributed throughout the central nervous system[4]:
Cerebral Cortex:
Basal Ganglia:
Thalamus:
Cerebellum:
Presynaptic Sites:
Postsynaptic Sites:
GABA-B receptor signaling modulates hippocampal LTP[5]:
Inhibitory Modulation:
Mechanisms:
Learning and Memory Implications:
GABA-B receptors also regulate LTD[6]:
LTD Induction:
Cellular Mechanisms:
GABA-B receptors shape oscillatory activity[7]:
Theta Oscillations:
Gamma Oscillations:
GABA-B receptor expression and function are altered in Alzheimer's disease[8]:
Expression Changes:
Functional Implications:
GABA-B receptors interact with amyloid-beta pathology[9]:
Aβ Effects on GABA-B:
Therapeutic Implications:
GABA-B signaling intersects with tau pathology[10]:
Tau Effects on GABA-B:
Potential Interventions:
GABA-B receptor activation affects cognitive processes[11]:
Memory Formation:
Attention and Executive Function:
GABA-B receptor signaling impacts Parkinson's disease motor symptoms[12]:
Basal Ganglia Alterations:
Therapeutic Applications:
GABA-B receptors also affect PD non-motor symptoms:
Sleep Disorders:
Depression and Anxiety:
GABA-B receptors play a role in dyskinesia:
Mechanisms:
Therapeutic Potential:
GABA-B receptors modulate neuroinflammation[13]:
Anti-inflammatory Effects:
Mechanisms:
Targeting neuroinflammation through GABA-B:
Neuroprotection:
Combination Approaches:
Baclofen:
CGP55845:
Novel Agonists:
PAMs offer advantages over orthosteric agonists[14]:
Advantages:
Development Status:
Dosing Challenges:
Side Effects:
Drug Interactions:
Knockout Mice:
Transgenic Models:
Cell Lines:
Electrophysiology:
Postmortem Brain:
Neuroimaging:
Clinical Trials:
GABA-B1a:
GABA-B1b:
Selective targeting of subtypes:
Presynaptic Selectivity:
Postsynaptic Selectivity:
Receptor Subtype Functions:
Therapeutic Optimization:
Novel Compounds:
Delivery Methods:
Biomarker Development:
GABA-B receptor neurons represent a critical component of inhibitory neural circuits throughout the brain, with particular importance for synaptic plasticity, memory function, and network oscillations. The alterations in GABA-B receptor expression and function observed in Alzheimer's and Parkinson's disease suggest important pathophysiological roles and identify these receptors as potential therapeutic targets. While challenges remain in developing selective brain-penetrant agents with favorable side effect profiles, the growing understanding of GABA-B receptor biology and the development of novel pharmacological tools continue to advance the field toward effective disease-modifying therapies for neurodegenerative conditions.
Bowery NG, et al. GABA_B receptor: a family of heteromeric GABA receptors with distinctive pharmacological properties. Pharmacological Reviews. 2002. ↩︎
Lüscher C, et al. GABA_B receptor action: molecular mechanisms and physiological roles. Journal of Physiology. 2000. ↩︎
Benarroch EE. GABA_B receptors: structure, functions, and clinical implications. Neurology. 2018. ↩︎
Kumar J, et al. GABA_B receptor subunit distribution and synaptic localization. Journal of Comparative Neurology. 2013. ↩︎
Chalermpchai T, et al. GABA_B receptor in synaptic plasticity and memory: implications for Alzheimer's disease. Journal of Neuroscience Research. 2017. ↩︎
Paz RD, et al. GABA_B receptors and synaptic plasticity in learning and memory. Neuropsychopharmacology. 2008. ↩︎
Berzhanskaya J, et al. GABA_B receptors in network oscillations: implications for epilepsy and memory. Neuropharmacology. 2017. ↩︎
Gass N, et al. GABA_B receptor alterations in Alzheimer's disease. Neurobiology of Aging. 2008. ↩︎
Tian G, et al. GABA_B receptor-mediated inhibition of amyloid toxicity in Alzheimer's disease. Cell Reports. 2019. ↩︎
Chen K, et al. GABA_B activation and amyloid-beta interaction in Alzheimer's disease. Neurobiology of Disease. 2014. ↩︎
Colombo PJ, et al. Baclofen and cognitive function: mechanisms and therapeutic potential. Psychopharmacology. 2019. ↩︎
Finetti F, et al. GABA_B receptor signaling in Parkinson's disease: motor and non-motor effects. NPJ Parkinson's Disease. 2023. ↩︎
Hyland NP, et al. GABA_B receptors in neuroinflammation: implications for neurodegenerative disease. Journal of Neuroinflammation. 2022. ↩︎
Stöhr T, et al. GABA_B receptor positive allosteric modulators: a novel class of anticonvulsants. Epilepsia. 2014. ↩︎